Interestingly, ACADL-mediated inhibition of HCC metastasis was not reversed by the addition of Etomoxir (a FAO inhibitor), suggesting that ACADL inhibition of HCC is independent of FAO, and other undiscovered mechanisms should be involved in the biological process. This evidence concerns the gene ACADL and hepatocellular carcinoma.